Beware Of Unapproved Stem Cell Treatments
(By Emily Bazar for California Healthline) A website for five affiliated stem cell clinics, four of them in California, hails
Read More
The Need To Replace EpiPens Regularly Adds To Concerns About Cost
(By Carmen Heredia Rodriguez for Kaiser Health News) As controversy about the pricing of EpiPens reverberates from Capitol Hill to
Read MoreMost Hospital Palliative Care Programs Are Understaffed
(By Michelle Andrews for Kaiser Health News) Most hospitals offer palliative care services that help people with serious illnesses manage their
Read MoreUnitedHealth And University Of California To Forge Unique Alliance
(By Chad Terhune for California Healthline) The nation’s largest health insurer and the University of California Health system are joining
Read MoreA Golden Ticket That Fast-Tracks A Drug Through The FDA
(By Sarah Jane Tribble for Kaiser Health News) Drugmaker Sarepta Therapeutics won a big victory when its $300,000 muscular dystrophy
Read MoreEuropean regulators appeal rulings that prevent release of drug data
(By Ed Silverman for STAT) Once again, drug makers and European regulators are clashing over disclosing information. Continue reading article
Read MoreSenate effort to increase access to experimental drugs is blocked
(By Ed Silverman for STAT) An effort to get the US Senate to pass a so-called Right to Try bill
Read MoreMost Americans believe prescription drug prices are unreasonable
(Ed Silverman for STAT) Roughly 8 in 10 Americans believe that prices for prescription drugs are unreasonable and support various
Read MoreStill No Permanent Solution to Veterans Health Administration
With the temporary Veterans Choice program about to expire next August or earlier if the $10 billion is exhausted sooner,
Read MoreSpecialty Drug Costs Soar 30% For California Pension Fund
(By Chad Terhune for California Healthline) Specialty drug costs jumped 30 percent last year to $587 million for the California
Read More